title: In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori.
abstract: The in vitro activities of amoxicillin, cefuroxime, ceftetrame, cefetamet, cefixime, tigemonam, erythromycin, roxithromycin, and dirithromycin against 30 clinical isolates of Campylobacter pylori were determined by an agar dilution technique. Roxithromycin and amoxicillin (MICs for 90% of isolates tested, 0.01 and 0.06 micrograms/ml, respectively) were the most active antibiotics tested, but all strains were susceptible to all antimicrobial agents tested.
authors.affiliation: Department of Microbiology, Hospital Clínico Universitario, Salamanca, Spain.
authors.forename: J A
authors.initials: JA
authors.lastname: García-Rodríguez
authors.forename: J E
authors.initials: JE
authors.lastname: García Sánchez
authors.forename: M I
authors.initials: MI
authors.lastname: García García
authors.forename: E
authors.initials: E
authors.lastname: García Sánchez
authors.forename: J L
authors.initials: JL
authors.lastname: Muñoz Bellido
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002167:Campylobacter / Q000187:drug effects*; D002169:Campylobacter Infections / Q000382:microbiology; D018942:Macrolides; D008826:Microbial Sensitivity Tests; D047090:beta-Lactams
chemical_list: D000900:Anti-Bacterial Agents; D018942:Macrolides; D047090:beta-Lactams